These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 11509650)

  • 1. Critical involvement of OX40 ligand signals in the T cell priming events during experimental autoimmune encephalomyelitis.
    Ndhlovu LC; Ishii N; Murata K; Sato T; Sugamura K
    J Immunol; 2001 Sep; 167(5):2991-9. PubMed ID: 11509650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD28-independent induction of experimental autoimmune encephalomyelitis.
    Chitnis T; Najafian N; Abdallah KA; Dong V; Yagita H; Sayegh MH; Khoury SJ
    J Clin Invest; 2001 Mar; 107(5):575-83. PubMed ID: 11238558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive OX40/OX40 ligand interaction induces autoimmune-like diseases.
    Murata K; Nose M; Ndhlovu LC; Sato T; Sugamura K; Ishii N
    J Immunol; 2002 Oct; 169(8):4628-36. PubMed ID: 12370402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of experimental autoimmune encephalomyelitis with anti-OX40 ligand monoclonal antibody: a critical role for OX40 ligand in migration, but not development, of pathogenic T cells.
    Nohara C; Akiba H; Nakajima A; Inoue A; Koh CS; Ohshima H; Yagita H; Mizuno Y; Okumura K
    J Immunol; 2001 Feb; 166(3):2108-15. PubMed ID: 11160262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis.
    Chang TT; Jabs C; Sobel RA; Kuchroo VK; Sharpe AH
    J Exp Med; 1999 Sep; 190(5):733-40. PubMed ID: 10477557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.
    Blazar BR; Sharpe AH; Chen AI; Panoskaltsis-Mortari A; Lees C; Akiba H; Yagita H; Killeen N; Taylor PA
    Blood; 2003 May; 101(9):3741-8. PubMed ID: 12521997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response.
    Gri G; Gallo E; Di Carlo E; Musiani P; Colombo MP
    J Immunol; 2003 Jan; 170(1):99-106. PubMed ID: 12496388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OX40-OX40 ligand interaction through T cell-T cell contact contributes to CD4 T cell longevity.
    Soroosh P; Ine S; Sugamura K; Ishii N
    J Immunol; 2006 May; 176(10):5975-87. PubMed ID: 16670306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple levels of activation of murine CD8(+) intraepithelial lymphocytes defined by OX40 (CD134) expression: effects on cell-mediated cytotoxicity, IFN-gamma, and IL-10 regulation.
    Wang HC; Klein JR
    J Immunol; 2001 Dec; 167(12):6717-23. PubMed ID: 11739485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costimulation through OX40 is crucial for induction of an alloreactive human T-cell response.
    Ukyo N; Hori T; Yanagita S; Ishikawa T; Uchiyama T
    Immunology; 2003 Jun; 109(2):226-31. PubMed ID: 12757617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
    Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K
    J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis.
    Yoshioka T; Nakajima A; Akiba H; Ishiwata T; Asano G; Yoshino S; Yagita H; Okumura K
    Eur J Immunol; 2000 Oct; 30(10):2815-23. PubMed ID: 11069062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells.
    Takeda I; Ine S; Killeen N; Ndhlovu LC; Murata K; Satomi S; Sugamura K; Ishii N
    J Immunol; 2004 Mar; 172(6):3580-9. PubMed ID: 15004159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of OX40-OX40 ligand interactions in langerhans cell function: enhanced contact hypersensitivity responses in OX40L-transgenic mice.
    Sato T; Ishii N; Murata K; Kikuchi K; Nakagawa S; Ndhlovu LC; Sugamura K
    Eur J Immunol; 2002 Nov; 32(11):3326-35. PubMed ID: 12555678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis.
    Akiba H; Miyahira Y; Atsuta M; Takeda K; Nohara C; Futagawa T; Matsuda H; Aoki T; Yagita H; Okumura K
    J Exp Med; 2000 Jan; 191(2):375-80. PubMed ID: 10637281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.
    Dawicki W; Bertram EM; Sharpe AH; Watts TH
    J Immunol; 2004 Nov; 173(10):5944-51. PubMed ID: 15528328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis.
    Weinberg AD; Wegmann KW; Funatake C; Whitham RH
    J Immunol; 1999 Feb; 162(3):1818-26. PubMed ID: 9973447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand.
    Murata K; Ishii N; Takano H; Miura S; Ndhlovu LC; Nose M; Noda T; Sugamura K
    J Exp Med; 2000 Jan; 191(2):365-74. PubMed ID: 10637280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of V alpha 14 NK T cells.
    Pál E; Tabira T; Kawano T; Taniguchi M; Miyake S; Yamamura T
    J Immunol; 2001 Jan; 166(1):662-8. PubMed ID: 11123351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis.
    Sun Y; Lin X; Chen HM; Wu Q; Subudhi SK; Chen L; Fu YX
    J Immunol; 2002 Feb; 168(3):1457-65. PubMed ID: 11801689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.